Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia

BACKGROUND: Additional chromosomal aberrations in Philadelphia chromosome-positive chronic myeloid leukemia are non-random and strongly associated with disease progression, but their prognostic impact and effect on treatment response is not clear. Point mutations in the BCR-ABL kinase domain are pro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kim, Theo D., Türkmen, Seval, Schwarz, Michaela, Koca, Gökben, Nogai, Hendrik, Bommer, Christiane, Dörken, Bernd, Daniel, Peter, le Coutre, Philipp
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2010
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857187/
https://ncbi.nlm.nih.gov/pubmed/20015884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.014712
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki